Revlon Named in Talc-Mesothelioma Lawsuit
Revlon Inc. on Tuesday became the latest corporation hit with a lawsuit alleging asbestos-contaminated talc in its cosmetic products caused mesothelioma cancer in a woman. A Maryland couple filed the lawsuit in New York state court. Laura McDaniel believes her diagnosis of mesothelioma in January stems from her father’s earlier employment with Revlon, the multinational skin care, fragrance and cosmetics giant headquartered in New York City. She is seeking $20 million in compensatory damage and $40 million in punitive damages. Husband Edward McDaniel wants $5 million for mental anguish and loss of companionship. More ...
Source: Asbestos and Mesothelioma News - February 26, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery
Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will measure the safety and efficacy of using two different immunotherapy drug regimens — Opdivo (nivolumab) and Yervoy (ipilimumab) — beginning 42 days before surgery. The hope is that at least one will make surgical resection more effective. Sidney Kimmel Cancer Center at Johns Hopkins University, MD Anderson Cancer Center at the University of Texas and Greenebaum Cancer Center at the University of Maryland are working together to enroll a...
Source: Asbestos and Mesothelioma News - February 24, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Detection May Come Earlier with Liquid Biopsy
Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer. The test has the potential to produce a much-earlier diagnosis of disease and the ability to personalize treatment and better predict a patient’s response to specific therapies. “We could change completely how this disease is viewed,” Dr. Brent Zanke, a specialist in diagnostic oncology and chief executive officer of Cellular Analytics, told The Mesothelioma Center at Asbestos.com. “It’s a proactive way to get...
Source: Asbestos and Mesothelioma News - February 18, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Gene Therapy for Mesothelioma Has ‘Real Potential’
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase III trial, known as the INFINITE clinical research study, is designed to evaluate the intrapleural delivery of an investigational drug — a type of gene therapy — in combination with celecoxib and gemcitabine, anti-inflammatory and chemotherapy drugs, respectively. Researchers hope to stop, or at least slow, the growth of mesothelioma tumor cells with the combination therapy. “This is a very interesting concept,” oncologist Dr. Bernardo G...
Source: Asbestos and Mesothelioma News - February 17, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Gene Therapy Trial Shows ‘Real Potential’
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase III trial, known as the INFINITE clinical research study, is designed to evaluate the intrapleural delivery of an investigational drug — a type of gene therapy — in combination with celecoxib and gemcitabine, anti-inflammatory and chemotherapy drugs, respectively. Researchers hope to stop, or at least slow, the growth of mesothelioma tumor cells with the combination therapy. “This is a very interesting concept,” oncologist Dr. Bernardo G...
Source: Asbestos and Mesothelioma News - February 17, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Alternative to Alimta Coming for Mesothelioma Patients
The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant mesothelioma and advanced stage non-small cell lung cancer. The approval will allow oncologists to offer an alternative to Alimta, which today is considered standard pemetrexed and manufactured by Eli Lilly and Company. The chemotherapy drug is designed to block DNA replication and cell division. However, Pemfexy will not be available until February 2022. The FDA approval is limited to pleural mesothelioma patients whose disease is unresectable. Pemfexy is produced by Eagle Pharm...
Source: Asbestos and Mesothelioma News - February 12, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Don ’t treat shortness of breath as trivial, GPs urged
It ’s a strong indicator of future serious ill health and early death, say researchers Related items fromOnMedica Illness poorly managed in those with learning disability Doctors warn of ‘feather duvet lung’ Road traffic pollution raises lung cancer risk NICE issues guidelines on neurological conditions UK asbestos regulations slammed (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 12, 2020 Category: UK Health Source Type: news

U.S. Government Experts, Industry Spar Over Asbestos Testing in Talc U.S. Government Experts, Industry Spar Over Asbestos Testing in Talc
Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 6, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

South Africa: Unpaid Asbestos Removal Workers Close Primary School
[GroundUp] "We ask for material and we are told we will share. They buy things in single boxes. Something is not right here," says worker (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 6, 2020 Category: African Health Source Type: news

FDA Moves Closer to Standardized Testing for Asbestos in Talc
The U.S. Food and Drug Administration moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos fibers. Experts from eight different federal agencies explained earlier recommendations at a day-long hearing. The session also featured input from 25 members of the public, which included industry representatives, consumer advocates and testing experts. “Standards are needed,” said Dr. Paul Howard, FDA Office of Regulatory Science, during his presentation. “They just don’t exist at this time.” Dr. Linda Katz, director of the FDA Office of ...
Source: Asbestos and Mesothelioma News - February 5, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Duke Completes Largest Study of Mesothelioma in Women
This study of women included 275 cases of pleural mesothelioma and 79 cases of peritoneal. Papillary mesothelioma and localized mesothelioma cases were excluded. Previous reports have shown that 22% to 29% of mesothelioma cases involve women, but only 12% in this particular study. Other Notable Takeaways The majority of those studied were exposed to asbestos through household contact. Women who worked in occupations and industries associated with higher asbestos exposure had objective markers of exposure similar to men. Survival was longer for the epithelial subtype of mesothelioma and magnified with the per...
Source: Asbestos and Mesothelioma News - February 5, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

FDA Examines Asbestos Testing at Public Hearing
For the first time in 50 years, the government agency is examining asbestos testing for talc powders and cosmetics after traces of the known carcinogen were found in a number of such products. (Source: CancerNetwork)
Source: CancerNetwork - February 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

U.S. government experts, industry spar over asbestos testing in talc
For the first time in nearly 50 years, the U.S. Food and Drug Administration examined asbestos testing for talc powders and cosmetics at a hearing on Tuesday, after traces of the known carcinogen were found in several such products, including Johnson& Johnson's Baby Powder. (Source: Reuters: Health)
Source: Reuters: Health - February 4, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

FDA to hold public meeting on testing for asbestos in talc
For the first time in nearly 50 years, the U.S. Food and Drug Administration will examine asbestos testing for talc powders and cosmetics at a hearing on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - February 4, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Mesothelioma Deaths Peak 30 Years After Asbestos Ban
Almost 30 years after Italy passed sweeping legislation that banned the mining, use and commercialization of asbestos, the country is facing the peak of its mesothelioma cancer crisis. The worst has just arrived. Asbestos may be the primary cause of mesothelioma, but banning it did not slow the rate of diagnosis or death from this rare and aggressive cancer. The International Journal of Environmental Research and Public Health published an in-depth study recently that examined the connection in Italy between its ban of asbestos and the deaths from mesothelioma. Researchers found there is no immediate benefit from an asbest...
Source: Asbestos and Mesothelioma News - January 30, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

J & J CEO Questioned Over Stock Sale Ahead of Story on Asbestos in Baby Powder J & J CEO Questioned Over Stock Sale Ahead of Story on Asbestos in Baby Powder
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 28, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

J & J CEO questioned over stock sale ahead of story on asbestos in Baby Powder
Johnson& Johnson Chief Executive Alex Gorsky on Monday faced questions from plaintiffs lawyers over the timing of his sale of company stock, as he testified for the first time in a jury trial over allegations that the company's Baby Powder causes cancer. Gorsky told the jury that he had sold company shares in November 2018, two days after a Reuters reporter contacted the company and summarized in an email her review of documents that showed J&J knew small amou (Source: Reuters: Health)
Source: Reuters: Health - January 28, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and efficacy when the vaccine is used in combination with standard-of-care chemotherapy for patients with inoperable pleural mesothelioma. Targovax, a Scandinavian pharmaceutical company developing the drug, is moving forward with another study combining ONCOS-102 with a checkpoint inhibitor drug such as Keytruda (pembrolizumab) or Opdivo (nivolumab), along with chemotherapy. “We have seen enough data at this point to be going ...
Source: Asbestos and Mesothelioma News - January 27, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

FDA Panel Recommends Standardized Talc Testing for Asbestos
A team of experts from eight different federal agencies has presented the U.S. Food and Drug Administration with preliminary recommendations to standardize the testing of talc for the presence of asbestos and other potentially harmful mineral products. The recommendations, some of which reject long-held talc industry positions, are designed to end the discrepancies in analysis of whether talc products are contaminated with cancer-causing substances. Preliminary recommendations will be part of the FDA’s public meeting on Feb. 4 to discuss and obtain scientific information on testing for asbestos in talc-based products...
Source: Asbestos and Mesothelioma News - January 21, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Teachers union suing district over asbestos in schools
The union representing public school teachers in Philadelphia has announced a lawsuit against the city's school district over its handling of asbestos contamination in schools (Source: ABC News: Health)
Source: ABC News: Health - January 20, 2020 Category: Consumer Health News Tags: Health Source Type: news

Study Uncovers Drug Combination for Sarcomatoid Mesothelioma
Researchers in Spain have discovered a drug combination showing potential in treating the most difficult-to-treat type of malignant mesothelioma. Selumetinib and AZD8186, already being studied separately in clinical trials for other cancers, displayed efficacy when used in combination on mesothelioma of the sarcomatoid cell type. Researchers at the Spanish National Cancer Research Centre made the discovery during their study using mice models and human tumor cells in the laboratory. “The findings, we hope, are relevant,” Dr. Paco Real, who led the study, told The Mesothelioma Center at Asbestos.com. “We d...
Source: Asbestos and Mesothelioma News - January 16, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Sept. 11 Responders May Be at Heightened Risk of Developing Leukemia
After the Twin Towers fell on Sept. 11, 2001, the thousands of people involved in rescue-and-cleanup efforts were exposed to carcinogens and other toxins as they breathed in contaminated air and dug through industrial rubble. Studies completed since then have shown elevated rates of conditions including multiple myeloma, prostate cancer and thyroid cancer among 9/11 responders and those who worked near the site. A new study published Jan. 14 in the journal JNCI Cancer Spectrum adds another to that list: leukemia. “After about 12 years of follow-up, there was an increase in the rate of all cancers combined, and separa...
Source: TIME: Health - January 14, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer Research Source Type: news

Researchers Find Potential New Target for Mesothelioma Treatment
An international research team has identified a novel molecular target with potential to significantly improve future treatment of malignant pleural mesothelioma. The recent findings could lead to a drug that targets key genetic inhibitors often preventing a patient’s own immune system from suppressing mesothelioma tumor growth. Dr. Antonio Giordano, part of the collaborative research team, said the goal is reducing mesothelioma mortality with a combinational therapy that includes this new target. “These findings help us define molecular mechanisms that may be key to mesothelioma aggressiveness and progression,...
Source: Asbestos and Mesothelioma News - January 14, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Government experts urge new talc testing standards amid asbestos worries
An expert panel formed by the U.S. Food and Drug Administration has endorsed asbestos testing standards for cosmetics that reject long-held industry positions and reflect those of public health authorities and experts for thousands of plaintiffs who allege contaminated talc products caused their cancers. (Source: Reuters: Health)
Source: Reuters: Health - January 11, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Pleural and Peritoneal Mesothelioma Combination Can Be Managed
A patient diagnosed with pleural and peritoneal mesothelioma today can survive well beyond expectations, provided personalized treatment can be found at a specialty center. Research from the Columbia University Medical Center in New York City has shown that despite the poor prognosis typically accompanies this rare diagnosis, patients still can thrive. “This is an understudied, and poorly understood, group of patients that often is just written off,” surgical oncologist Dr. Michael Kluger at Columbia told The Mesothelioma Center at Asbestos.com. “But we’ve shown a meaningful survival.” Kluger,...
Source: Asbestos and Mesothelioma News - January 9, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) Currently, there are few effective treatments for malignant mesothelioma, although it has been decades since it was found that the major risk factor is exposure to asbestos. The drugs identified by CNIO researchers are being tested on other types of cancer, which can speed up clinical trials for mesothelioma. The authors identified molecular markers that could be used to determine which patients could benefit most from this new therapy, provided that it is approved. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2020 Category: Cancer & Oncology Source Type: news

Study: No Major Link Between Baby Powder, Cancer
The use of talc powder has been linked to other types of cancer, such as mesothelioma. A jury recently awarded a California couple nearly $30 million from Johnson & Johnson for the wife's mesothelioma, according to a CNN report. (Source: WebMD Health)
Source: WebMD Health - January 7, 2020 Category: Consumer Health News Source Type: news

US Officials Respond to Asbestos Issue at Tokyo 2020 Water Polo Venue
Officials with USA Water Polo are confident that organizers of the 2020 Tokyo Summer Olympics will fix an ongoing asbestos issue at the water polo venue for this year’s games. Japanese newspaper The Asahi Shimbun originally reported that officials had discovered asbestos-containing insulation in at least two locations of the Tatsumi International Swimming Center in 2017. But the human carcinogen was not removed during renovations to the arena. Exposure to asbestos is the primary cause of mesothelioma, a deadly cancer with no definitive cure. Following reports of the asbestos issue, Tokyo 2020 organizers are taking...
Source: Asbestos and Mesothelioma News - January 6, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Johnson & Johnson Sued Over Baby Powder by New Mexico
The lawsuit claims the company targeted minority women and children despite being aware of the risk of asbestos in talc. (Source: NYT Health)
Source: NYT Health - January 3, 2020 Category: Consumer Health News Authors: Tiffany Hsu Tags: Drugs (Pharmaceuticals) Hazardous and Toxic Substances Suits and Litigation (Civil) Johnson & Valeant Pharmaceuticals International Inc Balderas, Hector H Jr Source Type: news

Mesothelioma Genetic Research Team Receives $2.6M Grant from NIH
Dr. Michele Carbone at the University of Hawaii Cancer Center has good reason to start 2020 optimistic about advancing the treatment of malignant pleural mesothelioma. The National Institutes of Health awarded his research team a five-year, $2.6 million grant last month to continue its work linking the BAP1 gene mutation to the development of mesothelioma cancer. It may hold the key to an eventual cure. “This [grant] moves us in the right direction. There is reason to be hopeful,” Carbone told The Mesothelioma Center at Asbestos.com. “There is one thing left to do, develop the resources to cure this horri...
Source: Asbestos and Mesothelioma News - January 2, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

St. Louis jury clears Johnson & Johnson in talc powder trial
Johnson& Johnson was cleared by a St. Louis jury of causing a Missouri woman's cancer that she blamed on asbestos-tainted talc powder, according to a report from Bloomberg. This is the company's eighth win this year in talc-related cases. A jury on Friday decided that the company's product did not contribute to the development of Vickie Forrest's ovarian cancer and did not fail to properly warn her about the powder's health risks, the report said. "The jury carefully considered the decades of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 23, 2019 Category: Biotechnology Authors: Veneta Rizvic Source Type: news

Study: Mesothelioma Patients with CD70 Protein Have Worse Prognosis
An international team of pathologists has identified a new protein often found on pleural mesothelioma tumor cells. The discovery could lead to a more accurate prognosis for patients and future treatment advances. Researchers found for the first time that mesothelioma patients expressing higher levels of the CD70 protein typically experience a much shorter survival, regardless of cell type or treatment type. “These markers might be useful for MPM [malignant pleural mesothelioma] prognostic evaluations, as well as targeted therapeutics,” the study authors wrote. “Further analyses in syngeneic mouse models...
Source: Asbestos and Mesothelioma News - December 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Canadian Town of Asbestos Changing Its Name for Economics
Officials in Asbestos, Quebec, have been struggling for years to develop a new identity for the small Canadian mining town. Changing its name might do the trick. Mayor Hugues Grimard announced recently that his town in southeastern Quebec is looking for a name change in 2020, believing it could spark a much-needed economic recovery. The natural link between the town’s name and the toxic mineral — once so compelling — has become a roadblock to any future development. Exposure to asbestos can lead to deadly diseases, including mesothelioma cancer. “There is really a negative perception around asbestos...
Source: Asbestos and Mesothelioma News - December 9, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Comparative Study Reveals Best Mesothelioma Surgery
Less is usually better than more when it comes to aggressive surgery for pleural mesothelioma, according to the latest and most-extensive comparative study. Throughout the last 25 years, surgical patients typically fared better with the lung-sparing pleurectomy and decortication (P/D) than with the more radical extrapleural pneumonectomy (EPP). “We found that the P/D approach should be preferred when technically feasible,” Dr. Dimitrios Magouliotis of the General University Hospital of Larissa in Greece, told The Mesothelioma Center at Asbestos.com. “We believe now the P/D should be the first choice.&rdqu...
Source: Asbestos and Mesothelioma News - December 5, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Powder Keg: FDA Bowed to Industry for Decades as Alarms Were Sounded Over Talc Powder Keg: FDA Bowed to Industry for Decades as Alarms Were Sounded Over Talc
At an invitation-only gathering late last year, U.S. regulators and their guests huddled at a hotel near Washington, D.C., to discuss the best way to detect cancer-causing asbestos in talc powders and cosmetics.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 5, 2019 Category: Intensive Care Tags: Hematology-Oncology News Source Type: news

Special Report: Powder Keg - FDA bowed to industry for decades as alarms were sounded over talc
At an invitation-only gathering late last year, U.S. regulators and their guests huddled at a hotel near Washington, D.C., to discuss the best way to detect cancer-causing asbestos in talc powders and cosmetics. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Johnson & Johnson says new tests show no asbestos in Johnson's Baby Powder
Johnson& Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after U.S. Food and Drug Administration investigations reported trace amounts of the material in the product earlier this year. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Company Investigation Confirms No Asbestos in Johnson ’s Baby Powder
More Than 150 Tests Show No Asbestos (Source: Johnson and Johnson)
Source: Johnson and Johnson - December 3, 2019 Category: Pharmaceuticals Source Type: news

DaSilva Building Mesothelioma Specialty Program in Orlando
Thoracic surgeon Dr. Marcelo DaSilva came to Orlando, Florida, with a lofty goal. He wants to make Central Florida a destination for patients diagnosed with malignant pleural mesothelioma. DaSilva also has the tools to make that goal a reality, building a mesothelioma specialty program at AdventHealth Orlando. “We want to make this a nationally — and internationally — recognized program,” DaSilva told The Mesothelioma Center at Asbestos.com. “People who come to Orlando will not only see Disney World, but they will see excellence in health care. We can do that here.” DaSilva was named chi...
Source: Asbestos and Mesothelioma News - December 3, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Powder Keg: FDA bowed to industry for decades as alarms were sounded over talc
At an invitation-only gathering late last year, U.S. regulators and their guests huddled at a hotel near Washington, D.C., to discuss the best way to detect cancer-causing asbestos in talc powders and cosmetics. (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Victory for staff as academy chain drops plans to axe jobs
UNISON has today (Wednesday) welcomed a decision by the Ormiston Academies Trust to drop plans to cut jobs across England, which it was feared could put the safety and support of pupils at primary and secondary schools at risk. The trust, which operates 38 schools across the country, had proposed cuts affecting up to 130 posts involving maintenance, caretaking and ICT (information and communications technology) roles. Employees at schools across the East of England, East Midlands, North West, South East, West Midlands and Yorkshire & Humberside faced a range of changes to their jobs including redundancies, pay cut...
Source: UNISON Health care news - November 27, 2019 Category: UK Health Authors: Charlotte Jeffs Tags: News Press release academies education Jon Richards Source Type: news

Report: 1.5 Million UK Buildings Contain Asbestos [Infographic]
Asbestos may have been banned in the United Kingdom 20 years ago, but the deadly carcinogen continues to be the leading cause of occupational death, leading to 5,500 deaths in the U.K. last year. According to a new report by ResPublica, an estimated six million tons of the deadly carcinogen remain inside 1.5 million buildings in the U.K., including schools and hospitals — many of which were built prior to the 1999 ban. Exposure to asbestos is directly connected to multiple diseases, including mesothelioma, lung cancer and asbestosis. Jump to the full infographic: Asbestos Risk in UK Hospital...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

Latest Mesothelioma Clinical Trial Opens at Memorial Sloan Kettering
Memorial Sloan Kettering Cancer Center in New York City has opened its latest clinical trial for patients with pleural mesothelioma, studying the effectiveness of an immunotherapy and chemotherapy combination prior to aggressive surgery. The novel feasibility study will determine if the use of Opdivo (nivolumab) with Alimta (pemetrexed) and either cisplatin or carboplatin — without delaying scheduled surgery — can significantly extend patient survival time. The hope is to duplicate earlier effectiveness of that same combination with other cancers. “It has been tried with promising results,” Memorial...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Six million TONNES of asbestos are still in schools and hospitals in the UK
A report by think-tank ResPublica said public sector workers in the UK may be breathing in small amounts of asbestos over long periods of time, which can eventually cause serious health problems. (Source: the Mail online | Health)
Source: the Mail online | Health - November 25, 2019 Category: Consumer Health News Source Type: news

Road traffic pollution raises lung cancer risk
Campaigners call for urgent action to hit pollution reduction targets Related items fromOnMedica UK asbestos regulations slammed High pollution days send hundreds to hospital Hitting clean air targets would prevent 10,000 UK child asthma cases Traffic pollution linked to 'millions' of childhood asthma cases Cars should be banned from around schools (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 25, 2019 Category: UK Health Source Type: news

UK asbestos regulations slammed
Report calls for central register of hospital and school buildings containing asbestos Related items fromOnMedica Sugary drinks linked to risk of overall and breast cancer Global cancer burden set to soar Decision to give boys HPV jab will save thousands of lives GPs key to new faster cancer diagnosis standards Over 100,000 cancer patients each year diagnosed too late (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 25, 2019 Category: UK Health Source Type: news

Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant...
(Impact Journals LLC) Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system. Comparing NSCLC PE and published plasma levels of CAR-T recipients, both were dominated by sIL-6R and IL-6 but NSCLC PE had more VEGF, FGF2 and TNF, and less IL-2, IL-4, IL-13, IL-15, MIP1 and IFN. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 22, 2019 Category: International Medicine & Public Health Source Type: news

Teacher diagnosed with mesothelioma to sue school district she claims exposed her to asbestos 
Lea DiRusso, 51, of South Philadelphia, Pennsylvania, was diagnosed with mesothelioma, a cancer of the tissue that lines the organs that she blames on asbestos-filled schools. (Source: the Mail online | Health)
Source: the Mail online | Health - November 21, 2019 Category: Consumer Health News Source Type: news

Celebrities Paint Masks for Mesothelioma Fundraising Event
The goal of the Pacific Mesothelioma Center is to be the most innovative nonprofit research and cancer treatment organization in the world. Its latest fundraising event is a perfect example. As part of the Pacific Heart, Lung & Blood Institute, the Pacific Mesothelioma Center will play a major role in the unMASKing the Cure for Cancer Gala, an innovative fundraising idea once used by Prince Charles more than 20 years ago. The November 21 event, held at the UCLA Luskin Conference Center, includes the auctioning of eclectic masks that were hand-painted by various celebrities, including actors, artists, athletes and music...
Source: Asbestos and Mesothelioma News - November 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news